These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3411310)

  • 1. Failure of influenza vaccination in the aged.
    Keren G; Segev S; Morag A; Zakay-Rones Z; Barzilai A; Rubinstein E
    J Med Virol; 1988 May; 25(1):85-9. PubMed ID: 3411310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to influenza vaccination].
    Alvarez I; Corral J; Arranz A; Foruria A; Landa V; Lejarza JR; Marijuán L; Martínez JM
    Aten Primaria; 1989; 6(7):494, 496-9. PubMed ID: 2518952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors.
    Muszkat M; Friedman G; Dannenberg HD; Greenbaum E; Lipo M; Heymann Y; Zakay-Rones Z; Ben-Yehuda A
    Exp Gerontol; 2003 Oct; 38(10):1199-203. PubMed ID: 14580873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination in heart transplant recipients.
    Fraund S; Wagner D; Pethig K; Drescher J; Girgsdies OE; Haverich A
    J Heart Lung Transplant; 1999 Mar; 18(3):220-5. PubMed ID: 10328147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
    Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for poor immune response to influenza vaccination in elderly people.
    Bellei NC; Carraro E; Castelo A; Granato CF
    Braz J Infect Dis; 2006 Aug; 10(4):269-73. PubMed ID: 17293910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.
    Song JY; Cheong HJ; Lee J; Woo HJ; Wie SH; Lee JS; Kim SW; Noh JY; Choi WS; Kim H; Kim KH; Kim WJ
    Vaccine; 2015 Oct; 33(41):5437-5444. PubMed ID: 26314625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of influenza vaccine among geriatric inpatients: effect of previous vaccination and antibody induction by single and twice injections].
    Ikematsu H; Nabeshima A; Yamaji K; Chong Y; Li W; Hayashi J; Goto S; Oka T; Shirai T; Kashiwagi S
    Kansenshogaku Zasshi; 1999 Oct; 73(10):1042-7. PubMed ID: 10565120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of inactivated influenza vaccine in residential homes for elderly people.
    Nicholson KG; Baker DJ; Chakraverty P; Farquhar A; Hurd D; Kent J; Litton PA; Smith SH
    Age Ageing; 1992 May; 21(3):182-8. PubMed ID: 1615780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to influenza vaccination in healthy adults.
    Brydak LB; Tadeusz S; Magdalena M
    Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased antibody response to influenza vaccine among nursing-home residents who received recalled vaccine--New York, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Dec; 45(50):1100-2. PubMed ID: 8999309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
    Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
    Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety of an influenza-split-vaccine in children].
    Schmitt-Grohé S; Banzhoff A; Klaassen B; Zielen S
    Klin Padiatr; 2001; 213(6):338-42. PubMed ID: 11713714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M; Beattie BL; McLean DM
    CMAJ; 1987 Oct; 137(8):722-6. PubMed ID: 3651943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza at Lowry Air Force Base in Denver, 1982-1986.
    Meiklejohn G; Zajac RA; Evans ME
    J Infect Dis; 1987 Oct; 156(4):649-51. PubMed ID: 3624907
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.
    Glathe H; Bigl S; Grosche A
    Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.